Kerstin Allen

1.2k total citations · 1 hit paper
22 papers, 833 citations indexed

About

Kerstin Allen is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Kerstin Allen has authored 22 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Kerstin Allen's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (7 papers) and Congenital Heart Disease Studies (5 papers). Kerstin Allen is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (7 papers) and Congenital Heart Disease Studies (5 papers). Kerstin Allen collaborates with scholars based in United States, United Kingdom and Japan. Kerstin Allen's co-authors include Xiao Ni, Raymond C. Rosen, Andre B. Araujo, Andrew M. Atz, Jonathan R. Kaltman, L. LuAnn Minich, Nancy S. Ghanayem, Alan B. Lewis, Peter C. Frommelt and Pirooz Eghtesady and has published in prestigious journals such as Circulation, Neurology and Annals of Neurology.

In The Last Decade

Kerstin Allen

20 papers receiving 811 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

2023 82 citations Sean J. Pittock, Michael Barnett et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Kerstin Allen

Since Specialization

Citations

This map shows the geographic impact of Kerstin Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Allen more than expected).

Fields of papers citing papers by Kerstin Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Allen. The network helps show where Kerstin Allen may publish in the future.

Co-authorship network of co-authors of Kerstin Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Allen. A scholar is included among the top collaborators of Kerstin Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Allen. Kerstin Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time to Vaccination After Rituximab (RTX) Discontinuation in Patients with anti–Aquaporin–4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): A Post-Hoc Analysis of the CHAMPION-NMOSD Trial (P11-8.011) 2025 ·Neurology ·Jeffrey L. Bennett, (unknown), Shamik Bhattacharyya, Aram Zabeti, (unknown), Kerstin Allen, Sean J. Pittock	0
2	Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder 2024 ·Frontiers in Neurology ·Stephan Ortiz, Sean J. Pittock, Achim Berthele, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Kerstin Allen, (unknown), Becky Parks, Ho Jin Kim	2
3	Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) 2024 ·Neurology ·(unknown), Kerstin Allen, Becky Parks	1
4	Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+ NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial (S32.003) 2024 ·Neurology ·Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, J. de Sèze, Michaël Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, (unknown), Kerstin Allen, Becky Parks, Ho Jin Kim	1
5	Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial (S5.002) 2023 ·Neurology ·Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, J. de Sèze, Michaël Levy, Ichiro Nakashima, (unknown), Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Kerstin Allen, (unknown), Marcus Yountz, Jung Bin Kim	1
6	Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder breakdown → 2023 ·Annals of Neurology ·Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, J. de Sèze, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Marcus Yountz, Kerstin Allen, (unknown), (unknown)	82
7	Clinical and real-world pharmacovigilance data of meningococcal infections in eculizumab- or ravulizumab-treated patients 2023 ·Journal of the Neurological Sciences ·(unknown), (unknown), (unknown), Becky Parks, (unknown), Kerstin Allen, Glen Frick, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
8	A Phase 3 Efficacy and Safety Study of Ravulizumab in Adult Patients With Neuromyelitis Optica Spectrum Disorder: Study Design and Methodology 2022 ·Neurology ·Sean J. Pittock, Kerstin Allen, Yasmin Mashhoon, Marcus Yountz	1
9	Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494) 2020 ·Neurology ·Dean M. Wingerchuk, Sean J. Pittock, Achim Berthele, Kazuo Fujihara, Ho Jin Kim, Michael Levy, Jacqueline Palace, Ichiro Nakashima, Murat Terzi, N. А. Totolyan, Shanthi Viswanathan, Kaichen Wang, Kerstin Allen, Kenji P. Fujita, Marcus Yountz, Róisín Armstrong	2
10	Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial 2012 ·Journal of Thoracic and Cardiovascular Surgery ·Nancy S. Ghanayem, Kerstin Allen, Sarah Tabbutt, Andrew M. Atz, Martha L. Clabby, David S. Cooper, Pirooz Eghtesady, Peter C. Frommelt, Peter J. Gruber, Kevin D. Hill, Jonathan R. Kaltman, Peter C. Laussen, Alan B. Lewis, (unknown), L. LuAnn Minich, Richard G. Ohye, (unknown), Steven M. Schwartz, Rakesh K. Singh, Caren S. Goldberg	268
11	Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle 2012 ·Journal of Thoracic and Cardiovascular Surgery ·James Cnota, Kerstin Allen, Steven D. Colan, Wesley Covitz, Eric M. Graham, David A. Hehir, Jami C. Levine, Renée Margossian, Brian W. McCrindle, L. LuAnn Minich, Shobha Natarajan, Marc E. Richmond, Daphne T. Hsu	22
12	Challenges and successes of recruitment in the “angiotensin-converting enzyme inhibition in infants with single ventricle trial” of the Pediatric Heart Network 2012 ·Cardiology in the Young ·Nancy A. Pike, Victoria L. Pemberton, Kerstin Allen, Jeffrey P. Jacobs, Daphne T. Hsu, Alan B. Lewis, Nancy S. Ghanayem, Linda M. Lambert, (unknown), Teresa Atz, Rosalind Korsin, (unknown), Chitra Ravishankar, James Cnota, Gail D. Pearson	8
13	Abstract 9897: Impact of Extracorporeal Membrane Oxygenation and Cardiopulmonary Resuscitation on Norwood Procedure Outcomes: Data from the Single Ventricle Reconstruction Trail 2011 ·Circulation ·Chitra Ravishankar, Sarah Tabbutt, Kerstin Allen, David S. Cooper, Deborah U. Frank, Peter C. Frommelt, Nancy S. Ghanayem, Caren S. Goldberg, Eric M. Graham, Joel A. Kirsh, Catherine D. Krawczeski, Wyman W. Lai, Alan B. Lewis, Andrew J. Lodge, Lynn Mahony, Janet M. Simsic, Lynn A. Sleeper, Mario Stylianou, Yanli Wang, Peter C. Laussen, (unknown)	1
14	Minimal Clinically Important Differences in the Vaginal Insertion and Successful Intercourse Items of the Sexual Encounter Profile 2011 ·The Journal of Sexual Medicine ·Andre B. Araujo, Kerstin Allen, Xiao Ni, Raymond C. Rosen	17
15	Minimal Clinically Important Differences in the Erectile Function Domain of the International Index of Erectile Function Scale 2011 ·European Urology ·Raymond C. Rosen, Kerstin Allen, Xiao Ni, Andre B. Araujo	320
16	1532 MINIMAL CLINICALLY IMPORTANT DIFFERENCES (MCID) IN THE ERECTILE FUNCTION (EF) DOMAIN OF THE INTERNATIONAL INDEX OF ERECTILE FUNCTION (IIEF) 2011 ·The Journal of Urology ·Raymond C. Rosen, Kerstin Allen, Xiao Ni, Andre B. Araujo	4
17	Tidal breathing parameters in young children: Comparison of measurement by respiratory inductance plethysmography to a facemask pneumotachograph system 1999 ·Pediatric Pulmonology ·(unknown), Anne Greenough, Richard Hooper, Kerstin Allen, (unknown), Jack Price, Gerrard F. Rafferty	14
18	Measurement of Glycated Haemoglobin by Boronate-Affinity High-Pressure Liquid Chromatography 1999 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), Kerstin Allen	3
19	A Novel Device for the Rapid In‐clinic Measurement of Haemoglobin A_1c 1993 ·Diabetic Medicine ·Richard M. Pope, (unknown), M. D. Page, Kerstin Allen, H. J. Bodansky	22
20	Prevalence of Haemoglobin Variants in a Diabetic Population and Their Effect on Glycated Haemoglobin Measurement 1992 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Kerstin Allen, Ashley Hamilton, H. J. Bodansky, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact